Study finds that compressing cells, and crowding their contents, can coax them to grow and divide.
Biological engineer discusses condensing the time taken to develop therapeutics down from many years to a matter of months.
Michael Birnbaum, Anders Hansen, and Tami Lieberman receive NIH Director’s New Innovator Awards from the NIH Common Fund’s High-Risk, High-Reward Research program.
MIT researchers find blocking the expression of the genes XPA and MK2 enhances the tumor-shrinking effects of platinum-based chemotherapies in p53-mutated cancers.
New technology cuts cell culture time by half and uses more targeted cell sorting and purification methods.
A CRISPR-based test developed at MIT and the Broad Institute can detect nearly as many cases as the standard Covid-19 diagnostic.
SMART researchers find exposing bacteria to hydrogen sulfide can increase antimicrobial sensitivity in bacteria that do not produce H2S.
Fund has launched a special summer round to spearhead projects addressing mental health, well-being, and racial justice at MIT.
The experimental drug has shown promise in early-stage clinical trials conducted in Singapore.
MIT students explore algal water purifiers, programmable soil bacteria, and other biological engineering approaches to food and water security.
C3.ai Digital Transformation Institute awards $5.4 million to top researchers to steer how society responds to the pandemic.
In lab tests, virus-like DNA structures coated with viral proteins provoke a strong immune response in human B cells.